Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyaRegen NCH gel for QoL after endometriosis surgery
NCT04023383Completed
- Sponsor
- Bakırköy Dr. Sadi Konuk Research and Training Hospital
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Polymer-based Nanoparticles, Hydrogel Systems
01
Overview
Randomised, double-blind trial of self-cross-linking sodium hyaluronate gel in tissue adhesions (2 arms), sponsored by Bakırköy Dr. Sadi Konuk Research and Training Hospital. Primary endpoint: Visual Analogue Scale symptom score at 6 months. Started Jan 2017; status: completed.
02
Drugs
self-cross-linking sodium hyaluronate gel
03
Conditions
tissue adhesions
Beyond the preview
Go deeper on NCT04023383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023383.